116 related articles for article (PubMed ID: 1930219)
1. Definition of the affinity of binding between human von Willebrand factor and coagulation factor VIII.
Ganz PR; Atkins JS; Palmer DS; Dudani AK; Hashemi S; Luison F
Biochem Biophys Res Commun; 1991 Oct; 180(1):231-7. PubMed ID: 1930219
[TBL] [Abstract][Full Text] [Related]
2. The pro-polypeptide of von Willebrand factor is required for the formation of a functional factor VIII-binding site on mature von Willebrand factor.
Leyte A; Voorberg J; Van Schijndel HB; Duim B; Pannekoek H; Van Mourik JA
Biochem J; 1991 Feb; 274 ( Pt 1)(Pt 1):257-61. PubMed ID: 1900418
[TBL] [Abstract][Full Text] [Related]
3. Binding of factor VIII to von willebrand factor is enabled by cleavage of the von Willebrand factor propeptide and enhanced by formation of disulfide-linked multimers.
Bendetowicz AV; Morris JA; Wise RJ; Gilbert GE; Kaufman RJ
Blood; 1998 Jul; 92(2):529-38. PubMed ID: 9657753
[TBL] [Abstract][Full Text] [Related]
4. Variant von Willebrand's disease: characterization of two subtypes by analysis of multimeric composition of factor VIII/von Willebrand factor in plasma and platelets.
Ruggeri ZM; Zimmerman TS
J Clin Invest; 1980 Jun; 65(6):1318-25. PubMed ID: 6773982
[TBL] [Abstract][Full Text] [Related]
5. Two distinct forms of Factor VIII coagulant protein in human plasma. Cleavage by thrombin, and differences in coagulant activity and association with von Willebrand factor.
Weinstein MJ; Chute LE
J Clin Invest; 1984 Feb; 73(2):307-16. PubMed ID: 6421875
[TBL] [Abstract][Full Text] [Related]
6. The interaction between human blood-coagulation factor VIII and von Willebrand factor. Characterization of a high-affinity binding site on factor VIII.
Leyte A; Verbeet MP; Brodniewicz-Proba T; Van Mourik JA; Mertens K
Biochem J; 1989 Feb; 257(3):679-83. PubMed ID: 2494987
[TBL] [Abstract][Full Text] [Related]
7. Comparison of two von Willebrand factor collagen-binding assays with different binding affinities for low, medium, and high multimers of von Willebrand factor.
Neugebauer BM; Goy C; Budek I; Seitz R
Semin Thromb Hemost; 2002 Apr; 28(2):139-48. PubMed ID: 11992237
[TBL] [Abstract][Full Text] [Related]
8. Effect of multimeric structure of the factor VIII/von Willebrand factor protein on binding to platelets.
Gralnick HR; Williams SB; Morisato DK
Blood; 1981 Aug; 58(2):387-97. PubMed ID: 6788111
[TBL] [Abstract][Full Text] [Related]
9. Binding of blood coagulation factor VIII and its light chain to phosphatidylserine/phosphatidylcholine bilayers as measured by ellipsometry.
Spaargaren J; Giesen PL; Janssen MP; Voorberg J; Willems GM; van Mourik JA
Biochem J; 1995 Sep; 310 ( Pt 2)(Pt 2):539-45. PubMed ID: 7654192
[TBL] [Abstract][Full Text] [Related]
10. Comparative study on collagen-binding enzyme-linked immunosorbent assay and ristocetin cofactor activity assays for detection of functional activity of von Willebrand factor.
Turecek PL; Siekmann J; Schwarz HP
Semin Thromb Hemost; 2002 Apr; 28(2):149-60. PubMed ID: 11992238
[TBL] [Abstract][Full Text] [Related]
11. Interaction of coagulation factor VIII with members of the low-density lipoprotein receptor family follows common mechanism and involves consensus residues within the A2 binding site 484-509.
Ananyeva NM; Makogonenko YM; Sarafanov AG; Pechik IV; Gorlatova N; Radtke KP; Shima M; Saenko EL
Blood Coagul Fibrinolysis; 2008 Sep; 19(6):543-55. PubMed ID: 18685438
[TBL] [Abstract][Full Text] [Related]
12. Dispersity of human factor VIII--Von Willebrand factor.
van Mourik JA; Bolhuis PA
Thromb Res; 1978 Jul; 13(1):15-24. PubMed ID: 308712
[No Abstract] [Full Text] [Related]
13. Factor VIII:C assay: influence of buffer components used in immunoaffinity chromatography for purification of factor VIII/von Willebrand factor.
Koops K; Hoff HS; Heethuis A; Das PC; Smit Sibinga CT
Thromb Res; 1994 May; 74(4):347-54. PubMed ID: 8085236
[TBL] [Abstract][Full Text] [Related]
14. Peptide affinity chromatography of human clotting factor VIII. Screening of the vWF-binding domain.
Necina R; Amatschek K; Schallaun E; Schwinn H; Josic D; Jungbauer A
J Chromatogr B Biomed Sci Appl; 1998 Sep; 715(1):191-201. PubMed ID: 9792510
[TBL] [Abstract][Full Text] [Related]
15. Evidence that a secondary binding and protecting site for factor VIII on von Willebrand factor is highly unlikely.
Layet S; Girma JP; Obert B; Peynaud-Debayle E; Bihoreau N; Meyer D
Biochem J; 1992 Feb; 282 ( Pt 1)(Pt 1):129-37. PubMed ID: 1531749
[TBL] [Abstract][Full Text] [Related]
16. von Willebrand factor protects the Ca2+-dependent structure of the factor VIII light chain.
Takeyama M; Nogami K; Okuda M; Shima M
Br J Haematol; 2009 Sep; 146(5):531-7. PubMed ID: 19594746
[TBL] [Abstract][Full Text] [Related]
17. Structural and functional characteristics of the B-domain-deleted recombinant factor VIII protein, r-VIII SQ.
Sandberg H; Almstedt A; Brandt J; Gray E; Holmquist L; Oswaldsson U; Sebring S; Mikaelsson M
Thromb Haemost; 2001 Jan; 85(1):93-100. PubMed ID: 11204595
[TBL] [Abstract][Full Text] [Related]
18. Surface-exposed hemophilic mutations across the factor VIII C2 domain have variable effects on stability and binding activities.
Spiegel PC; Murphy P; Stoddard BL
J Biol Chem; 2004 Dec; 279(51):53691-8. PubMed ID: 15471879
[TBL] [Abstract][Full Text] [Related]
19. Von Willebrand factor multimers in virus-inactivated plasmas and F VIII concentrates.
Budde U; Drewke E
Beitr Infusionsther Transfusionsmed; 1994; 32():408-14. PubMed ID: 9422121
[TBL] [Abstract][Full Text] [Related]
20. In vitro reactivity of factor VIII inhibitors with von Willebrand factor in different commercial factor VIII concentrates.
Tagariello G; Zanotto D; Radossi P; Sartori R; Belvini D; Salviato R
Am J Hematol; 2007 Jun; 82(6):460-2. PubMed ID: 17211843
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
